Skip to main content

10-09-2019 | Lung cancer | Video | Article

Researcher comment: Combining microRNAs and LDCT to assess lung cancer risk profiles

Ugo Pastorino discusses the bioMILD study, which investigates a lung cancer screening program that supplements low-dose computed tomography with a blood microRNA assay (3:09).

Read more about the bioMILD study here

Related topics